Extraction and quantification of the cationic lipid 1,2-dioleoyl-3-trimethylammonium propane from human plasma

Analytical Biochemistry

Volumn 363, Issue 1, 2007, Pages 157-159

  Koeber, Robert ^a   Pappas, Apostolos ^a   Michaelis, Uwe ^a   Schulze, Brita ^a  

^a MediGene AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

CATIONIC LIPIDS; HUMAN PLASMAS;

CHEMISTRY;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 1,2 DISTEARYL 3 TRIMETHYLAMMONIUM PROPANE; 2 PROPANOL; ACETONITRILE; CHLOROFORM; METHANOL; PROPANE; UNCLASSIFIED DRUG;

ARTICLE; EXTRACTION; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; PLASMA; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUPERNATANT; TANDEM MASS SPECTROMETRY;

EID: 33847387055     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.01.001     Document Type: Article

References (15)

1. Leventis R., and Silvius J.R. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles. Biochim. Biophys. Acta 1023 (1990) 124-132
2. Stamatatos L., Leventis R., Zuckermann M.J., and Silvius J.R. Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes. Biochemistry 27 (1998) 3917-3925
3. Thurston G., McLean J.W., Rizen M., Baluk P., Haskell A., Murphy T.J., Hanahan D., and McDonald D.M. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J. Clin. Invest. 101 (1998) 1401-1413
4. Kunstfeld R., Wickenhauser G., Michaelis U., Teifel M., Umek W., Naujoks K., Wolff K., and Petzelbauer P. Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model. J. Invest. Dermatol. 120 (2003) 476-482
5. Schmitt-Sody M., Strieth S., Krasnici S., Sauer B., Schulze B., Teifel M., Michaelis U., Naujoks K., and Dellian M. Neovascular targeting therapy: Paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy. Clin. Cancer Res. 9 (2003) 2335-2341
6. Ridwelski K., Kettner E., Fahlke J., Bartelheim K., Hitzl M., Schulze B., Koeber R., Michaelis U., Naujoks K., and Clemens M.R. Phase I study of the anti-neovascular agent MBT-0206 to evaluate safety and efficacy in patients with metastatic or advanced unresectable gastrointestinal cancer. J. Clin. Oncol. 22 (2004) 3163
7. Vernooij E.A., Kettenes-van den Bosch J.J., Underberg W.J.M., and Crommelin D.J.A. Chemical hydrolysis of DOTAP and DOPE in a liposomal environment. J. Control Release 79 (2002) 299-303
8. Chang C.D., and Harris D.J. Reversed-phase high performance liquid chromatographic analysis of cationic lipid-based gene transfer agents. J. Liquid Chromatogr. Rel. Technol. 21 (1998) 1119-1136
9. Meyer O., Roch O., Elmlinger D., and Kolbe H.V. Direct lipid quantitation of cationic liposomes by reversed-phase HPLC in lipoplex preparation process. Eur. J. Pharm. Biopharm. 50 (2000) 353-356
10. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
11. Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Washington, DC, 2001.
12. Zuidam N.J., and Barenholz Y. Characterization of DNA-lipid complexes commonly used for gene delivery. Intl. J. Pharm. 183 (1999) 43-46
13. Senior J.H., Trimble K.R., and Maskiewicz R. Interaction of positively-charged liposomes with blood: Implications for their application in vivo. Biochim. Biophys. Acta 1070 (1991) 173-179
14. Simberg D., Weiss A., and Barenholz Y. Reversible mode of binding of serum proteins to DOTAP/cholesterol lipoplexes: A possible explanation for intravenous lipofection efficiency. Human Gene Ther. 16 (2005) 1087-1096
15. P. L. Altman, D. S. Dittmer, Blood and other Body Fluids, Federation of the American Society of Experimental Biologists, Bethesda, MD, 1961.